DOI: 10.7504/nk2016070403
Clinical efficacy in the patients with myelodysplastic syndromes treated with ultra-low-dose decitabine combined with HAG regimen
LIU Li-na
ZHANG Qing-lan
LIU Yu-zhang
YU Feng-kuan
WEI Xu-dong
SONG Yong-ping
FANG Bai-jun
Keywords:myelodysplastic syndromesdecitabinecombined antineoplastic chemotherapy protocol
Publication Date:2016-01-01
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
